arrow
D

Dominik Dannehl

University of Cologne
H指数:12
被引数:581

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

PARP inhibition with olaparib and talazoparib for HER2-negative advanced breast cancer—Results from the prospective PRAEGNANT registry

奥拉帕利和塔拉佐帕利对HER2阴性晚期乳腺癌的PARP抑制——来自前瞻性PRAEGNANT登记研究的结果

2026-04-110
OAAI
Alpelisib and Fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the German PRAEGNANT trial

Alpelisib和Fulvestrant在德国PRAEGNANT试验中纳入的PIK3CA突变的激素受体阳性HER2阴性晚期乳腺癌

2026-04-020
OAAI
Impact of adjuvant endocrine therapy utilization in male patients with early breast cancer: results from a large German real-world claims data analysis

早期乳腺癌男性患者辅助内分泌治疗应用的影响:来自一项德国大型真实世界理赔数据分析的结果

2025-10-010
OAAI
The efficacy of sacituzumab govitecan and trastuzumab deruxtecan on stable and active brain metastases in metastatic breast cancer patientsda multicenter real-world analysis

sacituzumab govitecan和曲妥珠单抗deruxtecan对转移性乳腺癌患者稳定和活跃的脑转移的疗效a多中心真实世界分析

2024-05-017
OAAI